| Accession |
PRJCA023276 |
| Title |
Subgroup analysis of efficacy endpoints- potential relationship between objective response rate and co-mutation status |
| Relevance |
Medical |
| Data types |
Variation
Genome sequencing
|
| Organisms |
Homo sapiens
|
| Description |
In the subgroup analysis, we evaluated the potential relationship between objective response rate (ORR) and co-mutation status. A superior response was seen in patients with KRAS G12C and PIK3CA co-mutation, while an inferior response was seen in patients with KRAS G12C and STK11 or KEAP1 co-mutations. |
| Sample scope |
Multiisolate |
| Release date |
2024-01-26 |
| Grants |
| Agency |
program |
Grant ID |
Grant title |
| InventisBio
|
|
N/A
|
|
|
|
| Submitter |
Diandian
Wang (diandian.wang@inventisbio.com)
|
| Organization |
InventisBio Co., Ltd |
| Submission date |
2024-01-26 |
